Floatz logo

Anti-Human T-Lymphocyte Immunoglobulin, Rabbit

Leukemia

Peking University First Hospitalother_biologicalPhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
65/ 100

Competitive context

123 Active assets in the Leukemia cohort.

Asset / SponsorPhaseRating
Vincristine Sulfate
Inhye Ahn
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BB
Busulfanum
National Cancer Institute (NCI)
Phase 4BB
Pegaspargase
Dana-Farber Cancer Institute
Phase 3BB
Thioguanine Anhydrous
Incyte Corporation
Phase 3BB

View all 50 →

Same molecule, other indications

Anti-Human T-Lymphocyte Immunoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 2/3
75 / 100
View asset →
plasma cell myelomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →
myeloproliferative neoplasmActive
BB
Indicative · Phase 2/3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →